Agonist was administered by IP injection, and d-glucose (2 g kg 1 ) injected IP immediately, 4 or 8 h afterwards
The BPC-157 peptide is used in research on tissue healing, especially in tendon, ligament, muscle, and gut injuries
Since GLP-1 is cleaved by dipeptidyl peptidase-4 and has a half-life of less than 2 minutes, it is likely that intestinal GLP-1, released after eating, exerts its effect on the brain mainly by interacting with vagus afferent neurons located in the porta hepatis and pylorus
The trial will last for 24 weeks, with researchers tracking "changes in drinking, health, and quality of life to determine whether the medication offers a meaningful new treatment option." RELATED: New GLP-1 drugs could suppress desire for more than just food, study suggests Currently, more than 400,000 veterans in the U.S